Fulgent Genetics
FLGT
268 hedge funds and large institutions have $1.02B invested in Fulgent Genetics in 2021 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 95 increasing their positions, 80 reducing their positions, and 24 closing their positions.
75% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 24
19% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 80
6% more funds holding
Funds holding: 254 → 268 (+14)
1.79% more ownership
Funds ownership: 36.77% → 38.56% (+1.8%)
4% more capital invested
Capital invested by funds: $985M → $1.02B (+$38.3M)
6% less call options, than puts
Call options by funds: $68.1M | Put options by funds: $72.4M
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$28.5M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$22.1M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$20.4M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$9.78M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$9.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$18.1M |
| 2 |
SC
Sculptor Capital
New York
|
-$12.5M |
| 3 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$10.4M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$8.43M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.87M |
FLGT Hedge Fund Activity: Q3 2021 in Review
268 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q3 2021, worth a combined $1.02B — up 3.9% from $985M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new FLGT positions and 24 closed out — a net gain of 18 holders — while 95 added to existing stakes and 80 trimmed.
The largest buyer was BlackRock, adding an estimated $28.5M. The largest seller was Morgan Stanley, cutting an estimated $18.1M.
- 268 institutional investors held Fulgent Genetics (FLGT) as of Q3 2021, up from 254 in Q2 2021.
- Funds reported $1.02B of Fulgent Genetics stock for Q3 2021, up 3.9% quarter-over-quarter.
- 42 funds opened new Fulgent Genetics positions in Q3 2021 and 24 closed out, a net change of +18 holders.
- The largest Fulgent Genetics buyer in Q3 2021 was BlackRock, an estimated $28.5M added.
- The largest Fulgent Genetics seller in Q3 2021 was Morgan Stanley, an estimated $18.1M sold.
Based on aggregated 13F filings for Q3 2021.